Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/1/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Samer Fakhri

Wrong Dr. Samer Fakhri?

PROFESSOR and VICE CHAIR, PROGRAM...

The University of Texas Health Science Center at Houston
Phone: (210) ***-****  HQ Phone
Email: s***@***.edu
Local Address: Houston, Texas, United States
University of Texas Health Science Center
7703 Floyd Curl Drive Mail Code 7776
San Antonio , Texas 78229
United States

Company Description: The University of Texas Health Science Center at San Antonio is the leading research institution in South Texas and one of the major health sciences universities in...   more
Background

Employment History

  • Associate Professor and Program Director In the Department
    Otorhinolaryngology
  • Professor, Vice Chair and Residency Program Director
    The University of Texas Medical School at Houston
  • Rhinologist
    The University of Texas Medical School at Houston
  • Associate Professor and Residency Program Director
    The University of Texas Medical School at Houston
  • Surgeon
    Memorial Hermann Hospital
  • Associate Professor and Program Director In the Department of Otorhinolaryngology
    Memorial Hermann Hospital
  • Professor and Vice Chair
    Texas Medical Center
  • Associate Professor and Vice Chair
    Texas Medical Center
  • Associate Professor and Vice Chair
    Department of Otorhinolaryngology-Head & Neck Surgery University of Texas Medical School at Houston Texas Sinus Institute

Board Memberships and Affiliations

Education

  • MD
  • medical degree
    McGill University
30 Total References
Web References
Home - ENTvantageDX
www.entvantagedx.com, 30 Jan 2015 [cached]
Samer Fakhri, M.D.
...
Samer Fakhri, M.D.
Samer Fakhri, MD, is an internationally recognized rhinologist who is currently Professor, Vice Chair and Residency Program Director at The University of Texas Medical School at Houston. He currently serves as a committee member of the American Rhinologic Society and contributes yearly instructional courses to the American Academy of Otolaryngology-Head and Neck Surgery. In addition he is on the editorial board and a reviewer for Otolaryngology journals. He is a frequently invited national and international panelist and speaker. Dr. Fakhri has numerous scientific articles and book chapters. Dr. Fakhri's areas of clinical interest include medical and surgical management of refractory chronic rhinosinusitis and sinonasal polyposis, image-guided surgery, endoscopic lacrimal and orbital surgery, CSF leak repair, and minimally invasive skull base surgery.
Lifeline - Cord Blood Bank
www.lifelinecordblood.com, 19 Nov 2012 [cached]
The Principal Investigator is Samer Fakhri, MD, surgeon at Memorial Hermann-Texas Medical Centre and associate professor and program director in the Department of Otorhinolaryngology - Head & Neck Surgery at UTHealth.
...
"Currently, the only treatment options for sensorineural hearing loss are hearing aids or cochlear implants," Dr Fakhri said.
...
About 15 per cent of children in the US also suffer from low-frequency or high-frequency hearing loss that can impact the child's speech, language, and social development and can increase their risk of developing learning disabilities, according to Dr Fakhri.
"We share Dr Fakhri's and Dr Baumgartner's passion and commitment to understanding more about the potential applications of cord blood to help repair nerve tissue," said Heather Brown, vice president of scientific and medical affairs at CBR.
First FDA-Approved Stem Cell Trial to Treat Hearing Loss Begins
www.stemcellsportal.com, 14 July 2012 [cached]
The yearlong trial is led by Samer Fakhri, MD, an internationally recognized rhinologist who is currently an associate professor and residency program director at The University of Texas Medical School at Houston.
The researchers are following 10 children, aged 6 weeks to 18 months old, who have sustained post-birth SNHL. Children who are deaf as a result of a genetic anomaly or syndrome are not eligible.
The patients are treated using stem cells from their own stored umbilical cord blood. "Currently, the only treatment options for sensorineural hearing loss are hearing aids or cochlear implants," Dr. Fakhri said.
"There are a number of treatments ...
www.donmargolis.com, 1 July 2012 [cached]
"There are a number of treatments for hearing loss, but most of them rely on amplification of noises, not reversal of the hearing loss," said Dr. Samer Fakhri, associate professor and program director in the Department of Otorhinolaryngology at Memorial Hermann-Texas Medical Center, and principal investigator of the study.
...
Fakhri said it's still too early to determine whether the procedure benefitted Madeleine, or may be beneficial for other children.
...
"If there's any improvement, it should be detected within six months to a year," Fakhri said. "We can't determine from just one child if there's an overall benefit." If the study results show significant improvement overall among the collective children studied, children with acquired -- not genetic -- hearing loss, may be able to benefit from the procedure. "We do not recommend that stem cells at this point now should be a treatment modality for hearing loss," Fakhri said. Previous studies in mice suggest long-term hearing repair after stem cell infusion. Fakhri says it's likely that if the procedure works, children like Madeleine will have long-term restored hearing.
...
"The way the stem cells work is they support repair," said Fakhri.
...
Which is loss that has to do with the damage of the inner ear and nerve fibers that go to the brain," said Principal Investigator, Dr. Fakhri. Stem cells, saved from Madeline's own umbilical cord, were injected into her arm. "We expect that it will be safe. You are using your own blood stem cells as if it was your own transfusion," stated Dr. Fakhri.
...
"We can not expect what the results will be, but potentially it can repair and restore normal hearing," Fakhri said. Expensive stem cell treatments have gained negative attention for promising miraculous results.
Guest Archives | Radio Health Journal
www.mediatracks.com [cached]
Dr. Samer Fakhri, Associate Professor and Program Director, University of Texas Health Science Center and Children's Memorial Hermann Hospital
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304